Merck Antitrust Scheme Didn't Work, UK Says, Ending Probe
UK antitrust authorities announced Thursday that they'd dropped an investigation into Merck's discounting practices for its arthritis medicine Remicade not because it wasn't anticompetitive but because the discounts didn't create the...To view the full article, register now.
Already a subscriber? Click here to view full article